Antipsychotic drug use in children for mood/behavior disorders increases type 2 diabetes risk – Ceratin antipsychotic medications prescribed to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows.
Red meat linked to greater diabetes risk — Increasing amount of red meat in your diet ‘can raise risk of developing Type 2 Diabetes – Eating more red meat over time is associated with an increased risk of type-2 diabetes mellitus (T2DM) in a follow-up of three studies of about 149,000 U.S. men and women. “Our results confirm the robustness of the association between red meat and T2DM and add further evidence that limiting red meat consumption over time confers benefits for T2DM prevention,” says author.
US FDA approves three new drug treatments for type 2 diabetes – Nesina, Kazano, and Oseni – The U.S. Food and Drug Administration approved three new related products for use with diet and exercise to improve blood sugar control in adults with type 2 diabetes: Nesina (alogliptin) tablets, Kazano (alogliptin and metformin hydrochloride) tablets, and Oseni (alogliptin and pioglitazone) tablets.
Kidney disease accounts for most of the increased risk of dying early among diabetics — Preventing and treating kidney disease in those with diabetes could save lives – One in every 10 Americans has diabetes, and a third or more of those with the condition will develop kidney disease. That means almost 3 percent of Americans suffer from chronic kidney disease.
Study compares rate of death following diabetes diagnosis among normal weight and overweight adults — Thinner diabetics face higher death rate — New-onset diabetics with normal BMI have higher mortality rate than heavier diabetics – American adults of a normal weight with new-onset diabetes die at a higher rate than overweight/obese adults with the same disease. A Northwestern Medicine study found that normal-weight participants experienced both significantly higher total and non-cardiovascular mortality than overweight/obese participants.
McMaster study debunks belief insulin puts people with diabetes at risk of heart disease — International study involves more than 12,500 people in 40 countries over 6 years – Researchers at McMaster University have discovered that long-term insulin use does not harm people with diabetes or pre-diabetes or put them at risk of heart attacks, strokes or cancer. This is contrary to concerns that long-term use of insulin may cause heart disease, says Dr. Hertzel Gerstein, principal investigator of the study.
Restricted calorie diet improves heart function in obese patients with diabetes – A low-calorie diet eliminates insulin dependence and leads to improved heart function in obese patients with type 2 diabetes. It is striking to see how a relatively simple intervention of a very low calorie diet effectively cures type 2 diabetes mellitus. Moreover, these effects are long term.
Red meat linked to increased risk of type 2 diabetes — Processed red meats especially boost risk – A recently published study by Harvard School of Public Health (HSPH) finds a strong association between the consumption of red meat-particularly when the meat is processed-and an increased risk of type 2 diabetes.
Increased muscle mass may lower risk of pre-diabetes — Study shows building muscle can lower person’s risk of insulin resistance – The greater an individual’s total muscle mass, the lower the person’s risk of having insulin resistance, the major precursor of type 2 diabetes, revealed by researchers in a recent study accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM).
Two Studies Test Impact of Drugs to Slow Progression of Type 1 Diabetes – Abatacept (Orencia), an immune system modulator and GAD-alum, an antigen based therapy found beneficial for patients with type 1 diabetes. TrialNet researchers are conducting a series of studies to test ways to prevent or delay progression of type 1 diabetes. Results of two studies testing drugs to slow or stop the immune system’s attack on insulin-producing cells in people newly diagnosed with type 1 diabetes will be presented at the American Diabetes Association’s (ADA) 71st Scientific Sessions in San Diego and simultaneously published online in the Lancet.